O

OliPass Corp
KOSDAQ:244460

Watchlist Manager
OliPass Corp
KOSDAQ:244460
Watchlist
Price: 1 651 KRW -13.92% Market Closed
Market Cap: 9B KRW

Net Margin
OliPass Corp

-1 631.5%
Current
-2 554%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 631.5%
=
Net Income
-11.2B
/
Revenue
686.9m

Net Margin Across Competitors

No Stocks Found

OliPass Corp
Glance View

Market Cap
9B KRW
Industry
Biotechnology

OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

OliPass Corp Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 631.5%
=
Net Income
-11.2B
/
Revenue
686.9m
What is the Net Margin of OliPass Corp?

Based on OliPass Corp's most recent financial statements, the company has Net Margin of -1 631.5%.

Back to Top